Adenosine Actions are Preserved in Corpus Cavernosum from Obese and Type II Diabetic db/db Mouse
- 1 May 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 5 (5) , 1156-1166
- https://doi.org/10.1111/j.1743-6109.2007.00752.x
Abstract
Erectile dysfunction (ED) in diabetes is associated with autonomic neuropathy and endothelial dysfunction. Whereas the nonadrenergic-noncholinergic (NANC)/neurogenic nitric oxide pathway has received great attention in diabetes-associated ED, few studies have addressed sympathetic overactivity. To test the hypothesis that adenosine-induced inhibition of adrenergic-mediated contractile responses in mouse corpus cavernosum is impaired in the presence of diabetes. The db/db (obesity and type II diabetes caused by a leptin receptor mutation) mouse strain was used as a model of obesity and type II diabetes, and standard procedures were performed to evaluate functional cavernosal responses. Increased cavernosal responses to sympathetic stimulation in db/db mice are not associated with impaired prejunctional actions of adenosine. Electrical field stimulation (EFS)-, but not phenylephrine (PE)-, induced contractions are enhanced in cavernosal strips from db/db mice in comparison with those from lean littermates. Direct effects of adenosine, 2-chloro-adenosine, A1 receptor agonist C-8031 (N6 cyclopentyladenosine), and sodium nitroprusside are similar between the strips from lean and db/db mice, whereas relaxant responses to acetylcholine and NANC stimulation are significantly impaired in the cavernosal strips from db/db mice. 5′-Iodotubercidin (adenosine kinase inhibitor) and dipyridamole (inhibitor of adenosine transport), as well as the A1 agonist C-8031, significantly and similarly inhibit contractions induced by stimulation of adrenergic nerves in the cavernosal strips from lean and db/db mice. Results from this study suggest that corpora cavernosa from obese and diabetic db/db mice display altered neural-mediated responses that would favor penile detumescence, i.e., increased contractile response to adrenergic nerve stimulation and decreased relaxant responses upon activation of NANC nerves. However, increased cavernosal responses to adrenergic nerve stimulation are not due to impaired negative modulation of sympathetic neurotransmission by adenosine in this diabetic model. Carneiro FS, Giachini FRC, Lima VV, Carneiro ZN, Leite R, Inscho EW, Tostes RC, and Webb RC. Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse.Keywords
Funding Information
- National Institutes of Health (HL71138, HL74167)
This publication has 54 references indexed in Scilit:
- Determination of Adenosine Effects and Adenosine Receptors in Murine Corpus CavernosumThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Antisense and Short Hairpin RNA (shRNA) Constructs Targeting PIN (Protein Inhibitor of NOS) Ameliorate Aging-Related Erectile Dysfunction in the RatThe Journal of Sexual Medicine, 2007
- Loss of nitrergic neurotransmission to mouse corpus cavernosum in the absence of neurturin is accompanied by increased response to acetylcholineBritish Journal of Pharmacology, 2006
- Historical review: ATP as a neurotransmitterTrends in Pharmacological Sciences, 2006
- Reduced coronary reserve in response to short‐term ischaemia and vasoactive drugs in ex vivo hearts from diabetic miceActa Physiologica, 2006
- Cyclic Nucleotide Signaling in Cavernous Smooth MuscleThe Journal of Sexual Medicine, 2005
- CHOLINERGIC NERVES IN HUMAN CORPUS CAVERNOSUM AND SPONGIOSUM CONTAIN NITRIC OXIDE SYNTHASE AND HEME OXYGENASEJournal of Urology, 2000
- NO synthase in cholinergic nerves and NO‐induced relaxation in the rat isolated corpus cavernosumBritish Journal of Pharmacology, 1999
- Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans.Journal of Clinical Investigation, 1993
- Pharmacological Effects of Adenosine on Canine Penile Erection.The Tohoku Journal of Experimental Medicine, 1991